Form 4: Adaptimmune Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Cintia Piccina, Chief Commercial Officer of Adaptimmune Therapeutics, sold shares to cover tax obligations related to the vesting of RSU-style share options.
Summary
- Cintia Piccina, the Chief Commercial Officer of Adaptimmune Therapeutics PLC, executed a transaction involving the sale of American Depositary Shares (ADS) on June 18, 2024.
- The sale was conducted to cover tax withholding obligations and associated sale costs related to the vesting of RSU-style share options.
- Piccina sold 24,531 ADSs at a price of $0.93 per ADS.
- Following the transaction, Piccina directly owns 38,293 ADSs.
- Piccina also holds 54,359 ADSs and RSU-style options and other options covering an aggregate of 6,968,400 ordinary shares of the Issuer.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. This transaction appears to be a routine 'sell to cover' event.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of grant of RSU-style share option covering ordinary shares of the Issuer. |
| 06/18/2024 | Date of transaction: sale of ADSs and signature date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.